Hilarey R.F. Bhatt, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 31 years
- University of California, San Francisco School of Medicine, 1995
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhatt’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$113,857
Medicare paid this office $113,857 for 546 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 332 | $39,983 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 153 | $22,628 | $148 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 59 | $16,127 | $273 |
| Short return visit (20+ min) | 218 | $15,237 | $57 |
| Long return visit (40+ min) | 15 | $2,795 | $140 |
See all 11 services
| Return visit (30+ min) | 332 | $39,983 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 153 | $22,628 | $148 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 59 | $16,127 | $273 |
| Short return visit (20+ min) | 218 | $15,237 | $57 |
| Long return visit (40+ min) | 15 | $2,795 | $140 |
| Return visit (30+ min) | 30 | $2,637 | $88 |
| Administration of pneumococcal vaccine | 58 | $2,246 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 124 | $1,938 | $13 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,918 | $58 |
| Short return visit (20+ min) | 12 | $654 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $159 | $11 |
Who their Medicare patients are
546 Original Medicare patients in 2024. Average age 77 · Women 72% · Also on Medicaid 6% · Health risk score 0.93. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 57% · Coronary heart disease 20% · Cancer 19% · Atrial fibrillation 18% · Depression 15% · Diabetes 13% · Chronic kidney disease 12% · Heart failure 10% · Stroke 10% · COPD 6% · Dementia 6%.
The office billed $628,256, Medicare allowed $158,818 and paid $113,857; for 1,331 services of 30 kinds; $16,704 of it was for drugs given in the office and $97,153 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 546 | 1,331 | 77 | 0.93 | $628,256 | $113,857 |
| 2023 | 703 | 2,275 | 77 | 0.78 | $1,122,693 | $217,422 |
| 2022 | 688 | 1,585 | 77 | 0.82 | $692,014 | $165,208 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 545 | $93,870 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 337 | $48,858 | $145 |
| Short return visit (20+ min) | 341 | $33,950 | $68 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 32 | $8,600 | $269 |
| Telephone medical discussion with physician, 11-20 minutes | 75 | $5,536 | $64 |
| Long return visit (40+ min) | 30 | $5,396 | $150 |
| Pneumococcal vaccine, 23-valent | 27 | $3,532 | $131 |
| Influenza vaccine split virus, preservative free | 46 | $3,381 | $72 |
| Administration of pneumococcal vaccine | 65 | $2,397 | $36 |
| Administration of influenza virus vaccine | 51 | $1,889 | $36 |
| New patient visit (45+ min) | 19 | $1,746 | $92 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,653 | $97 |
| Short return visit | 15 | $621 | $41 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $515 | $43 |
| Urinalysis, manual test | 20 | $78 | $3 |
2022: 15 services
| Return visit (30+ min) | 396 | $66,405 | $126 |
| Short return visit (20+ min) | 292 | $36,892 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 145 | $21,108 | $146 |
| New patient visit (45+ min) | 38 | $6,915 | $182 |
| Telephone medical discussion with physician, 11-20 minutes | 49 | $4,953 | $95 |
| Long return visit (40+ min) | 25 | $4,567 | $183 |
| Influenza vaccine split virus, preservative free | 66 | $4,524 | $69 |
| Short return visit | 58 | $3,889 | $64 |
| Administration of influenza virus vaccine | 90 | $3,248 | $36 |
| Pneumococcal vaccine, 23-valent | 24 | $3,154 | $131 |
| New patient visit (30+ min) | 21 | $2,612 | $124 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 24 | $1,645 | $69 |
| Telephone medical discussion with physician, 5-10 minutes | 19 | $1,166 | $61 |
| Administration of pneumococcal vaccine | 24 | $870 | $36 |
| Urinalysis, manual test | 34 | $134 | $3 |
Drugs they prescribed that Part D paid
$164,846
Pharmacies billed $164,846 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (79 of 2,919) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,654 generic and 249 brand-name prescriptions · $164,846 in drug cost · 100 antibiotic prescriptions to 74 people · 33 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 29 | $24,084 | $830 |
| Ozempic | 19 | $18,186 | $957 |
| Wixela Inhub | 28 | $3,143 | $112 |
| Atorvastatin | 221 | $2,855 | $13 |
| Duloxetine | 26 | $2,491 | $96 |
See all 61 drugs
| Eliquis | 29 | $24,084 | $830 |
| Ozempic | 19 | $18,186 | $957 |
| Wixela Inhub | 28 | $3,143 | $112 |
| Atorvastatin | 221 | $2,855 | $13 |
| Duloxetine | 26 | $2,491 | $96 |
| Levothyroxine | 157 | $2,121 | $14 |
| Estradiol | 34 | $1,878 | $55 |
| Gabapentin | 118 | $1,381 | $12 |
| Escitalopram | 77 | $1,332 | $17 |
| Amlodipine Besylate | 153 | $1,172 | $8 |
| Metoprolol | 58 | $1,017 | $18 |
| Albuterol Sulfate Hfa | 37 | $937 | $25 |
| Rosuvastatin | 80 | $887 | $11 |
| Baclofen | 17 | $883 | $52 |
| Lisinopril | 88 | $806 | $9 |
| Mirtazapine | 26 | $793 | $31 |
| Losartan | 74 | $761 | $10 |
| Celecoxib | 34 | $708 | $21 |
| Tamsulosin | 42 | $607 | $14 |
| Pregabalin | 14 | $558 | $40 |
| Pantoprazole | 51 | $551 | $11 |
| Trazodone | 64 | $549 | $9 |
| Quetiapine | 33 | $514 | $16 |
| Tramadol | 53 | $501 | $9 |
| Ipratropium | 11 | $443 | $40 |
| Hydralazine | 17 | $378 | $22 |
| Prednisone | 28 | $378 | $13 |
| Temazepam | 33 | $377 | $11 |
| Omeprazole | 15 | $344 | $23 |
| Donepezil | 19 | $311 | $16 |
| Spironolactone | 12 | $283 | $24 |
| Hydrocodone-Acetaminophen | 14 | $282 | $20 |
| Diazepam | 28 | $282 | $10 |
| Enalapril Maleate | 14 | $272 | $19 |
| Amoxicillin-Clavulanate Potass | 26 | $265 | $10 |
| Metoprolol | 23 | $256 | $11 |
| Zolpidem | 51 | $249 | $5 |
| Sertraline | 29 | $249 | $9 |
| Fluticasone Propionate | 20 | $237 | $12 |
| Simvastatin | 20 | $204 | $10 |
| Furosemide | 14 | $201 | $14 |
| Propranolol | 14 | $191 | $14 |
| Metformin | 11 | $185 | $17 |
| Lorazepam | 51 | $182 | $4 |
| Cyclobenzaprine | 17 | $179 | $11 |
| Allopurinol | 22 | $177 | $8 |
| Citalopram Hbr | 17 | $171 | $10 |
| Alendronate | 22 | $148 | $7 |
| Sumatriptan | 14 | $144 | $10 |
| Meloxicam | 38 | $142 | $4 |
| Carvedilol | 12 | $141 | $12 |
| Nitrofurantoin Mono-Macro | 13 | $127 | $10 |
| Acyclovir | 11 | $118 | $11 |
| Hydrochlorothiazide | 30 | $111 | $4 |
| Ondansetron | 13 | $109 | $8 |
| Valacyclovir | 13 | $102 | $8 |
| Benazepril | 13 | $100 | $8 |
| Alprazolam | 25 | $89 | $4 |
| Azithromycin | 21 | $75 | $4 |
| Triamcinolone Acetonide | 11 | $58 | $5 |
| Paxlovid | 22 | $0 | $0 |
Year by year
| 2024 | 2,919 | 595 | 3% (79) | 9% | $164,846 |
| 2023 | 6,117 | 815 | 3% (170) | 10% | $371,312 |
| 2022 | 2,193 | 639 | 3% (55) | 10% | $136,268 |
| 2014 | 17 | None | 0% (0) | None | $396 |
| 2013 | 164 | 31 | None | 9% | $4,825 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 109 drugs
| Eliquis | 82 | $61,227 | $747 |
| Xarelto | 27 | $24,396 | $904 |
| Symbicort | 28 | $13,701 | $489 |
| Linzess | 12 | $12,190 | $1,016 |
| Flovent Hfa | 40 | $11,706 | $293 |
| Januvia | 12 | $11,283 | $940 |
| Advair Diskus | 24 | $9,499 | $396 |
| Spiriva Respimat | 16 | $8,527 | $533 |
| Myrbetriq | 12 | $8,498 | $708 |
| Repatha Sureclick | 12 | $8,327 | $694 |
| Testosterone | 17 | $7,068 | $416 |
| Levothyroxine | 392 | $6,903 | $18 |
| Atorvastatin | 586 | $6,573 | $11 |
| Estradiol | 57 | $5,063 | $89 |
| Wixela Inhub | 37 | $4,048 | $109 |
| Pulmicort Flexhaler | 13 | $3,735 | $287 |
| Synthroid | 35 | $3,346 | $96 |
| Escitalopram | 168 | $3,240 | $19 |
| Albuterol Sulfate Hfa | 97 | $3,108 | $32 |
| Duloxetine | 58 | $2,989 | $52 |
| Gabapentin | 185 | $2,882 | $16 |
| Celecoxib | 42 | $2,733 | $65 |
| Rosuvastatin | 127 | $2,730 | $21 |
| Yuvafem | 14 | $2,708 | $193 |
| Metoprolol | 124 | $2,618 | $21 |
| Losartan | 159 | $2,309 | $15 |
| Trazodone | 140 | $2,274 | $16 |
| Amlodipine Besylate | 242 | $2,144 | $9 |
| Baclofen | 43 | $1,847 | $43 |
| Lisinopril | 195 | $1,838 | $9 |
| Colchicine | 17 | $1,567 | $92 |
| Tamsulosin | 73 | $1,551 | $21 |
| Ezetimibe | 26 | $1,308 | $50 |
| Azelastine | 14 | $1,206 | $86 |
| Mirtazapine | 40 | $1,149 | $29 |
| Quetiapine | 64 | $1,140 | $18 |
| Pantoprazole | 82 | $1,119 | $14 |
| Bupropion Xl | 29 | $1,118 | $39 |
| Hydrocodone-Acetaminophen | 44 | $1,049 | $24 |
| Ventolin Hfa | 17 | $1,047 | $62 |
| Potassium Chloride | 16 | $1,046 | $65 |
| Rizatriptan | 15 | $1,021 | $68 |
| Simvastatin | 93 | $980 | $11 |
| Propranolol | 31 | $958 | $31 |
| Sertraline | 75 | $913 | $12 |
| Alendronate | 66 | $866 | $13 |
| Zolpidem | 104 | $857 | $8 |
| Fluoxetine | 35 | $783 | $22 |
| Omeprazole | 56 | $708 | $13 |
| Prednisone | 59 | $699 | $12 |
| Allopurinol | 42 | $688 | $16 |
| Pregabalin | 18 | $680 | $38 |
| Metformin | 55 | $626 | $11 |
| Valacyclovir | 29 | $613 | $21 |
| Ipratropium | 21 | $586 | $28 |
| Ultra-Fine Nano Pen Needle | 14 | $532 | $38 |
| Oxybutynin Chloride Er | 11 | $524 | $48 |
| Amoxicillin-Clavulanate Potass | 27 | $523 | $19 |
| Paxlovid (Eua) | 52 | $517 | $10 |
| Progesterone | 13 | $517 | $40 |
| Tramadol | 80 | $517 | $6 |
| Doxepin | 14 | $507 | $36 |
| Venlafaxine Hcl Er | 14 | $495 | $35 |
| Ibandronate | 16 | $494 | $31 |
| Acyclovir | 30 | $489 | $16 |
| Enalapril Maleate | 12 | $468 | $39 |
| Sumatriptan | 19 | $468 | $25 |
| Finasteride | 23 | $462 | $20 |
| Lorazepam | 115 | $448 | $4 |
| Cephalexin | 38 | $421 | $11 |
| Fluticasone Propionate | 27 | $413 | $15 |
| Montelukast | 27 | $397 | $15 |
| Temazepam | 41 | $384 | $9 |
| Liothyronine | 12 | $374 | $31 |
| Meloxicam | 87 | $362 | $4 |
| Cyclobenzaprine | 33 | $361 | $11 |
| Valsartan-Hydrochlorothiazide | 16 | $353 | $22 |
| Donepezil | 22 | $339 | $15 |
| Metoprolol | 50 | $337 | $7 |
| Digoxin | 21 | $334 | $16 |
| Divalproex | 12 | $328 | $27 |
| Citalopram Hbr | 28 | $327 | $12 |
| Hydrochlorothiazide | 62 | $322 | $5 |
| Nitrofurantoin Mono-Macro | 24 | $319 | $13 |
| Famotidine | 17 | $288 | $17 |
| Clopidogrel | 15 | $288 | $19 |
| Doxycycline Hyclate | 20 | $251 | $13 |
| Olmesartan Medoxomil | 16 | $250 | $16 |
| Chlorthalidone | 14 | $248 | $18 |
| Spironolactone | 14 | $242 | $17 |
| Diazepam | 48 | $241 | $5 |
| Hydrocortisone | 13 | $237 | $18 |
| Triamterene-Hydrochlorothiazid | 22 | $234 | $11 |
| Azithromycin | 34 | $223 | $7 |
| Paroxetine | 12 | $222 | $18 |
| Benazepril | 12 | $217 | $18 |
| Triamcinolone Acetonide | 22 | $203 | $9 |
| Furosemide | 18 | $202 | $11 |
| Metformin Hcl Er | 19 | $185 | $10 |
| Pravastatin | 19 | $152 | $8 |
| Acetaminophen-Codeine | 11 | $135 | $12 |
| Carvedilol | 20 | $135 | $7 |
| Lactulose | 12 | $102 | $9 |
| Topiramate | 11 | $94 | $9 |
| Lisinopril-Hydrochlorothiazide | 13 | $87 | $7 |
| Lamotrigine | 12 | $87 | $7 |
| Alprazolam | 22 | $76 | $3 |
| Sulfamethoxazole-Trimethoprim | 14 | $38 | $3 |
| Amoxicillin | 13 | $35 | $3 |
2022: 51 drugs
| Eliquis | 38 | $22,225 | $585 |
| Levothyroxine | 137 | $2,702 | $20 |
| Wixela Inhub | 16 | $2,317 | $145 |
| Synthroid | 20 | $1,898 | $95 |
| Atorvastatin | 197 | $1,866 | $9 |
| Estradiol | 28 | $1,580 | $56 |
| Albuterol Sulfate Hfa | 37 | $1,368 | $37 |
| Escitalopram | 78 | $1,350 | $17 |
| Celecoxib | 27 | $1,347 | $50 |
| Gabapentin | 59 | $1,194 | $20 |
| Rosuvastatin | 39 | $1,100 | $28 |
| Baclofen | 12 | $826 | $69 |
| Tamsulosin | 41 | $802 | $20 |
| Trazodone | 48 | $723 | $15 |
| Paxlovid (Eua) | 66 | $689 | $10 |
| Potassium Chloride | 11 | $614 | $56 |
| Lisinopril | 60 | $610 | $10 |
| Nitrofurantoin Mono-Macro | 20 | $604 | $30 |
| Hydrocodone-Acetaminophen | 23 | $597 | $26 |
| Valacyclovir | 17 | $591 | $35 |
| Simvastatin | 34 | $493 | $14 |
| Losartan | 42 | $486 | $12 |
| Zolpidem | 48 | $467 | $10 |
| Sertraline | 26 | $462 | $18 |
| Mirtazapine | 21 | $437 | $21 |
| Duloxetine | 15 | $426 | $28 |
| Amlodipine Besylate | 65 | $423 | $7 |
| Quetiapine | 16 | $420 | $26 |
| Metoprolol | 18 | $409 | $23 |
| Omeprazole | 20 | $352 | $18 |
| Allopurinol | 11 | $347 | $32 |
| Metformin | 22 | $268 | $12 |
| Alendronate | 34 | $256 | $8 |
| Propranolol | 12 | $242 | $20 |
| Finasteride | 11 | $209 | $19 |
| Pantoprazole | 22 | $203 | $9 |
| Prednisone | 15 | $187 | $12 |
| Temazepam | 12 | $141 | $12 |
| Lorazepam | 32 | $139 | $4 |
| Cephalexin | 11 | $136 | $12 |
| Tramadol | 26 | $134 | $5 |
| Triamcinolone Acetonide | 18 | $129 | $7 |
| Meloxicam | 26 | $116 | $4 |
| Cyclobenzaprine | 15 | $107 | $7 |
| Diazepam | 21 | $100 | $5 |
| Doxycycline Hyclate | 11 | $90 | $8 |
| Azithromycin | 13 | $83 | $6 |
| Hydrochlorothiazide | 31 | $80 | $3 |
| Metoprolol | 12 | $74 | $6 |
| Sulfamethoxazole-Trimethoprim | 20 | $51 | $3 |
| Ciprofloxacin | 11 | $40 | $4 |
2013: 2 drugs
| Gabapentin | 11 | $879 | $80 |
| Atorvastatin | 14 | $398 | $28 |
Professional record
- NPI
- 1417044819
- Licence
- CA A062752
- Trained
- University of California, San Francisco School of Medicine, 1995 · 31 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-10-06
- NPI last updated
- 2024-11-07
- NPI record certified
- 2024-11-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4150 Clement St, San Francisco, CA, 94121